Resources and management strategies for the use of radiotherapy in the treatment of lung cancer in Central and Eastern European countries: Results of an International Atomic Energy Agency (IAEA) survey

• Published in: Lung cancer (Amsterdam, Netherlands) Netherlands), 2007-05, Vol.56 (2), p.235-245
• Main Authors: Kepka, Lucyna, Danilova, Vera, Saghatelyan, Tatul, Bajcsay, Andras, Utehina, Olga, Stojanovic, Suzana, Yalman, Deniz, Demiral, Ayse, Bondaruk, Olga, Kuddu, Maire, Jeremic, Branislav
• Format: Article
• Language: English
• Subjects: Antineoplastic Agents - therapeutic use; Combined Modality Therapy; Data Collection; Developing countries; Developing Countries - statistics & numerical data; Europe; Health Resources; Health Services Accessibility; Hematology, Oncology and Palliative Medicine; Humans; International Agencies; Lung Neoplasms - drug therapy; Lung Neoplasms - radiotherapy; NSCLC; Patterns of care survey; Practice Patterns, Physicians' - statistics & numerical data; Pulmonary/Respiratory; Radiation Oncology - statistics & numerical data; Radiotherapy; Radiotherapy - utilization; SCLC
• ISSN: 0169-5002; 1872-8332
• DOI: 10.1016/j.lungcan.2006.12.011

Summary Purpose To assess resources and management strategies for the use of radiotherapy (RT) in the treatment of lung cancer in developing Central and Eastern European countries. Materials/methods Questionnaires on patterns of care of NSCLC and SCLC were sent to radiation oncologists of Central and Eastern Europe. Comparisons were made between two groups of countries-ex-USSR states and other Eastern and Central European countries. Results Twenty-four out of twenty-eight surveyed countries responded. There were significant differences in access to modern treatment facilities (3D planning systems, number of linear accelerators), percentage of patients with lung cancer receiving radiotherapy, schedules of palliative RT, use of postoperative RT for early stages between both analysed groups of countries. 3D systems were in use in 25% of centres for an entire treatment, in 28% for a part of the treatment, and in 47% curative RT was 2D planned. Sequential chemo-RT was the most common approach to radical management of NSCLC, followed by RT alone and concomitant chemo-RT; median percentages of patients receiving respective treatments per centre were 57%, 30%, and 10%. For SCLC, the concurrent approach was declared by 56%, and the sequential approach by 42% of responders. Conclusions Patterns of care of lung cancer in the analysed countries differed in some part from existing, evidence-based data on lung cancer. In particular, this difference was observed between ex-USSR countries and the rest of European developing countries in the equipment available and specific diagnostic and treatment parameters in radiotherapy of lung cancer, the latter group's practices more resembling those of developed European countries.